Long-term outcomes of surgical ventricular reconstruction: Insight from cardiac magnetic resonance

Gianluigi Guida1, Serenella Castelvecchio2, Giandomenico Disabato1

  • 1Cardiology University Department, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy; Multimodality imaging Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

PubMed

Insights

Surgical ventricular reconstruction (SVR) improves symptoms and left ventricular (LV) function in ischemic heart failure (HF) patients. Long-term survival is predicted by clinical factors and cardiac magnetic resonance imaging (CMR) parameters, including the LGE/LVEDVi ratio.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Ischemic heart failure (HF) significantly impacts patient morbidity and mortality.
  • Surgical ventricular reconstruction (SVR) is a therapeutic option for selected patients with severe left ventricular (LV) dysfunction.
  • Evaluating outcomes and predictors of survival after SVR is crucial for optimizing patient management.

Purpose of the Study:

  • To assess clinical and cardiac magnetic resonance (CMR) outcomes following SVR in patients with ischemic HF.
  • To identify independent predictors of long-term all-cause mortality after SVR.

Main Methods:

  • A cohort of 126 patients with severe LV systolic dysfunction and symptomatic HF underwent SVR.
  • Cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE) was performed pre- and post-surgery.
  • Cox regression analysis was employed to determine predictors of mortality.

Main Results:

  • SVR led to significant improvements in NYHA class and LV ejection fraction (LVEF) at 6 months.
  • The ratio of LGE to LV end-diastolic volume index (LGE/LVEDVi) was the only CMR parameter associated with mortality.
  • Independent predictors of all-cause mortality included age, NYHA class III, moderate-to-severe mitral regurgitation, pulmonary artery systolic pressure (PASP), and LGE/LVEDVi ratio.

Conclusions:

  • SVR effectively improves symptoms and LV function in patients with ischemic HF.
  • Clinical variables and the LGE/LVEDVi ratio derived from CMR are significant predictors of long-term survival.
Abstract